Abstract
Isoniazid, a first-line antibiotic used for the treatment of tuberculosis, is a prodrug that requires activation by the Mycobacterium tuberculosis enzyme KatG. The KatG(S315T) mutation causes isoniazid resistance while the KatG(R463L) variation is thought to be a polymorphism. Much of the work to date focused on isoniazid activation by KatG has utilized recombinant enzyme overexpressed in Escherichia coli. In this work, native KatG and KatG(S315T) were purified from M. tuberculosis, and KatG(R463L) was purified from Mycobacterium bovis. The native molecular weight, enzymatic activity, optical, resonance Raman, and EPR spectra, K(D) for isoniazid binding, and isoniazid oxidation rates were measured and compared for each native enzyme. Further, the properties of the native enzymes were compared and contrasted with those reported for recombinant KatG, KatG(S315T), and KatG(R463L) in order to assess the ability of the recombinant enzymes to act as good models for the native enzymes.
References
Jul 1, 1975·The Biochemical Journal·B G DeviK P Gopinathan
May 7, 1976·Analytical Biochemistry·M M Bradford
Aug 13, 1992·Nature·Y ZhangS Cole
Mar 1, 1985·Antimicrobial Agents and Chemotherapy·H A ShoebA J Merola
Sep 22, 1995·The Journal of Biological Chemistry·J A MarcinkevicieneJ S Blanchard
Jan 1, 1995·Molecular Microbiology·B HeymS T Cole
Nov 29, 1994·Biochemical Pharmacology·J M Van Zyl, B J Van der Walt
Feb 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·B P VareldzisA Kochi
May 1, 1993·Molecular Microbiology·Y ZhangD Young
Jan 1, 1996·The Journal of Infectious Diseases·J M MusserJ D van Embden
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·D A RouseS L Morris
Nov 1, 1996·Molecular Microbiology·D A RouseS L Morris
Jan 31, 1997·The Journal of Biological Chemistry·K JohnssonP G Schultz
Apr 4, 1997·The Journal of Biological Chemistry·R S Magliozzo, J A Marcinkeviciene
Sep 18, 1997·The Journal of Infectious Diseases·N L WengenackF Rusnak
Feb 12, 1998·The Journal of Biological Chemistry·J M NagyK A Brown
Jun 11, 1998·Emerging Infectious Diseases·A RattanN Ahmad
Dec 8, 1998·Biochemistry·N L WengenackF Rusnak
Mar 2, 1999·Chemotherapy·P Sander, E C Böttger
Mar 3, 1999·The Biochemical Journal·B Saint-JoanisS T Cole
Mar 19, 1999·Biochemical and Biophysical Research Communications·N L WengenackM K Stern
May 13, 1999·Thorax·A Telenti
Jan 25, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ramaswamy, J M Musser
Aug 10, 2000·Biochemistry·S ChouchaneR S Magliozzo
Aug 10, 2000·Biochemistry·G S Lukat-RodgersK R Rodgers
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Vanja M BulatovicFrank Rusnak
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·C E BarryK Mdluli
Citations
Nov 28, 2013·Archives of Biochemistry and Biophysics·Olive J NjumaDouglas C Goodwin
Oct 15, 2011·Bioresource Technology·Shefali SangarRavinder S Jolly
Sep 11, 2013·MicrobiologyOpen·Amy Cunningham-BusselCarl F Nathan
Jan 8, 2010·Protein Science : a Publication of the Protein Society·Christine E CadeReza A Ghiladi
May 16, 2015·The Journal of Antimicrobial Chemotherapy·Elena MartinezVitali Sintchenko
May 5, 2016·Scientific Reports·Ting WangGang Zhao
Aug 25, 2016·Tuberculosis·Florence BrossierWladimir Sougakoff
Apr 4, 2017·Molecular Biology and Evolution·Anastasia S KochRobert J Wilkinson
Sep 1, 2016·Ukrainian biochemical journal· PurkanH S Kusuma
Oct 26, 2005·The Journal of Biological Chemistry·Christa JakopitschChristian Obinger
Oct 30, 2008·Biochemistry·Kalina RanguelovaRichard S Magliozzo